Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant - PA: Epigenetics/epigenomics in human health or disease

University of Ottawa

$100,000.00

Transcriptional Regulation of Impaired Neurogenesis in Developmental Disorders of Cognition and Intellectual Disability

FY 2022-23

Summary
The costs of developmental disorders of cognition and intellectual disability (ID) are enormous. No effective treatments are available for ID and thus there is an urgent need for improved understanding of these disorders. X-linked intellectual disability (XLID) affects 1 to 3 percent of the population and is clinically characterized by a deficit in intellectual function with an intelligence quotient (IQ) of less than 70 before the age of 18. Gene deletions, duplications, inversions and point mutations on the X chromosome have been associated with XLID. The Börjeson-Forssman-Lehmann syndrome (BFLS) was first described as an XLID syndrome by Mats Börjeson and colleagues in 1962. The main clinical features of BFLS become apparent with age. Developmental delay usually appears before the first birthday. All BFLS patients have intellectual disabilities, ranging from mild to severe. Multiple mutations in the PHF6 gene on the X chromosome have been identified in BFLS patients. In this proposal, we will investigate the mechanisms by which impaired PHF6 function drives neurodevelopmental defects and leads to the pathogenesis of BFLS. The results obtained from these studies will be of biological and clinical relevance for better understanding and treatment of neurodevelopmental disorders.
Program
Project Grant - PA: Epigenetics/epigenomics in human health or disease
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
472573
Name
Jahani-Asl Arezu
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Cell Biology - Disease
Projecttitle
Transcriptional Regulation of Impaired Neurogenesis in Developmental Disorders of Cognition and Intellectual Disability
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Epigenetics/epigenomics in human health or disease
Keyworddelim
Ephrin Receptors; Gene Mutation; Receptors; Signalling; Stem Cells; Transcription
Abstract
The costs of developmental disorders of cognition and intellectual disability (ID) are enormous. No effective treatments are available for ID and thus there is an urgent need for improved understanding of these disorders. X-linked intellectual disability (XLID) affects 1 to 3 percent of the population and is clinically characterized by a deficit in intellectual function with an intelligence quotient (IQ) of less than 70 before the age of 18. Gene deletions, duplications, inversions and point mutations on the X chromosome have been associated with XLID. The Börjeson-Forssman-Lehmann syndrome (BFLS) was first described as an XLID syndrome by Mats Börjeson and colleagues in 1962. The main clinical features of BFLS become apparent with age. Developmental delay usually appears before the first birthday. All BFLS patients have intellectual disabilities, ranging from mild to severe. Multiple mutations in the PHF6 gene on the X chromosome have been identified in BFLS patients. In this proposal, we will investigate the mechanisms by which impaired PHF6 function drives neurodevelopmental defects and leads to the pathogenesis of BFLS. The results obtained from these studies will be of biological and clinical relevance for better understanding and treatment of neurodevelopmental disorders.
Competitiondate
202209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jahani-Asl, Arezu
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
University of Ottawa - $100,000 Grant (2022-23) | Canada Spends